Polymorphisms of FTO and adiponectin genes can be used (in addition to age and BMI at time of diagnosis) in the model of obesity prediction after breast cancer treatment [26]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.